Global Vitamin D Therapy Market Forecasts to 2024 - Lucrative Opportunities in Countries with a High Prevalence of Under-Nutrition - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 8, 2019--The “Vitamin D Therapy Market by Route of administration, Age Group, Purchase Pattern, Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period.
Growth in this market is largely driven by the growing awareness about vitamin D deficiency, growing focus on healthy diets among consumers, and the presence of a large target patient population. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. On the other hand, the fortification of foods is likely to challenge market growth to a certain extent.
The major players operating in this market are Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India).
Oral route of administration accounted for a significant share of the market, by route of administration, in 2018
By route of administration, the vitamin D therapy market is segmented into oral and parenteral routes of administration. In 2018, the oral route of administration accounted for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. This is mainly due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, and a higher preference for the oral route.
By purchasing pattern, prescription drugs held the largest share of the vitamin D therapy market in 2018
On the basis of purchasing pattern, the vitamin D therapy market is segmented into OTC and prescription drugs. In 2018, the prescription drugs segment accounted for the largest share of the vitamin D therapy market. The large share of this segment can be attributed to the fact that vitamin D deficiency is mostly diagnosed by registered medical practitioners that provide prescriptions for appropriate medications.
Asia Pacific dominated the vitamin D therapy market in 2018
The Asia Pacific, which includes China, Japan, India, and the Rest of Asia Pacific, accounted for the largest share of the vitamin D therapy market. The large share of this market segment can be attributed to the increasing awareness about vitamin D deficiency and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, atypical diets, decreasing sun exposure, and rising malnutrition levels.
Key Topics Covered
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Vitamin D: Market Overview
4.2 North America: Vitamin D Therapy Market, By Route of Administration (2019)
4.3 Geographical Snapshot of the Vitamin D Therapy Market
5 Market Overview
5.2 Market Dynamics
220.127.116.11 Growing Awareness About Vitamin D Deficiency Among Consumers
18.104.22.168 Presence of A Large Target Patient Population
5.2.2 Market Opportunities
22.214.171.124 Growth Opportunities in Countries With A High Prevalence of Under-nutrition
5.2.3 Market Challenges
126.96.36.199 Fortified Foods
6 Role of Vitamin D in Disease Progression
6.1 Role of Vitamin D in the Prevention and Treatment of Cancer
6.2 Role of Vitamin D in the Prevention and Treatment of Diabetes
6.3 Role of Vitamin D in the Prevention and Treatment of Cardiovascular Diseases
7 Vitamin D Therapy Market, By Route of Administration
7.2 Oral Route of Administration
7.3 Parenteral Route of Administration
8 Vitamin D Therapy Market, By Purchasing Pattern
8.2 Prescription Drugs
8.3 Over-The-Counter Drugs
9 Vitamin D Therapy Market, By Application
9.4 Muscle Weakness
9.5 Autoimmune Disorders
9.6 Skin Diseases
9.7 Other Applications
10 Vitamin D Therapy Market, By Age Group
10.2 Senior Adults
11 Vitamin D Therapy Market, By Region
11.2 North America
11.4 Asia Pacific
11.5 Rest of the World
12 Competitive Landscape
12.2 Market Ranking Analysis, 2018
12.3 Key Strategies
12.3.1 Acquisitions and Collaborations, 2015-2018
12.4 Competitive Leadership Mapping (2018)
12.4.1 Visionary Leaders
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies
13 Company Profiles
13.1 Novartis AG
13.2 Pfizer Inc.
13.3 GlaxoSmithKline PLC
13.4 Merck & Co. Inc.
13.7 Torrent Pharmaceuticals Ltd.
13.8 Sun Pharmaceutical Industries Ltd.
13.9 Alkem Laboratories Ltd.
13.10 Cadila Healthcare Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/34qbi7
View source version on businesswire.com:https://www.businesswire.com/news/home/20190508005401/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Vitamins and Dietary Supplements
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/08/2019 06:49 AM/DISC: 05/08/2019 06:48 AM